Hop-based dietary supplements that many women use to ease the night sweats and hot flashes commonly reported during menopause aren’t likely to cause drug interactions, new research from Oregon State University’s Linus Pauling Institute and College of Pharmacy shows.
The findings are important because while hormone replacement therapy remains the standard of care for menopausal patients, not all women are good candidates for it. Some studies have suggested hormone replacement therapy puts women at an increased risk for breast cancer and cardiovascular disease, sparking interest in alternative treatments.
Hops are the flowers of the hops plant and are what gives beer its bitter flavor. Supplements made from hops can be effective for alleviating menopausal symptoms because hops contain phytoestrogens. Phytoestrogens are plant-based compounds that mimic the action of female sex hormones, whose deficiency is at the root of symptoms often felt by women in menopause, which also include sleep disturbances, fatigue and vaginal dryness.
“There are reports from other lab studies that compounds from hops may inhibit or deactivate certain drug-metabolizing enzymes,” said the study’s lead investigator and corresponding author, Richard van Breemen, director and principal investigator of the Linus Pauling Institute. “There is additional concern because we know the compounds in hops have a long half-life in humans, possibly more than 20 hours after taking them.”
The long half-life means hops supplements may still be found in the bloodstream when women take drugs they are prescribed. Because these botanical supplements are made from plants, many people don’t think of the possibility of drug interactions when they take them.
To determine hops’ effect on drug-metabolizing enzymes, the scientists gave 16 research subjects a cocktail of four drugs, each one primarily metabolized by a different enzyme in a family of enzymes known as cytochrome P450s. The drugs were caffeine; alprazolam, an anti-anxiety medicine sold under the trade name Xanax; dextromethorphan, an over-the-counter cough suppressant; and tolbutamide, a medicine used to treat type 2 diabetes.
“We did each drug trial twice. Once to see how these women metabolized the drugs normally,” van Breemen explained. “Then we repeated the trial with hops after the participants took a hops extract twice daily for two weeks. Thankfully, no enzyme inhibition was detected.”
Guidelines for clinical studies of drug interactions involving CYP enzymes have been set by the U.S. Food and Drug Administration, he noted.
Source: Read Full Article